Related Experiment Video

Updated: Jun 4, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Osteosarcoma: a review of diagnosis, management, and treatment strategies

David S Geller1, Richard Gorlick

  • 1Department of Orthopaedic Surgery, Montefiore Medical Center, Bronx, NY 10467, USA. dgeller@montefiore.org

Clinical Advances in Hematology & Oncology : H&O
|February 15, 2011
PubMed

Insights

Osteosarcoma treatment has not improved survival rates for decades due to tumor variability. Future progress likely lies in combining targeted therapies with conventional chemotherapy for better osteosarcoma outcomes.

Area of Science:

  • Oncology
  • Cancer Research
  • Orthopedic Oncology

Background:

  • Osteosarcoma survival rates have stagnated for over 20 years despite diagnostic and therapeutic advancements.
  • Tumor heterogeneity in osteosarcoma presents a significant challenge, limiting the efficacy of single-target treatment strategies.

Purpose of the Study:

  • To review the current state of osteosarcoma treatment and identify key challenges.
  • To explore potential future directions for improving patient survival outcomes in osteosarcoma.

Main Methods:

  • Literature review of advancements in osteosarcoma diagnosis and treatment.
  • Analysis of factors contributing to the lack of survival improvement.
  • Evaluation of the role of chemotherapy and targeted therapies.

Main Results:

  • Current diagnostic and treatment protocols, including awareness and referral, have not significantly improved overall survival.
  • Multi-agent chemotherapy has historically yielded the most substantial survival benefits.

Conclusions:

  • Improving osteosarcoma survival necessitates addressing tumor variability.
  • Combination-targeted chemotherapy alongside conventional treatments holds the most promise for future survival improvements in osteosarcoma patients.

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...